Buy Gliclazide (Diamicron) Powder Raw APIS anti-diabetic medication For diabetes mellitus type 2 Online CAS 21187-98-4
Gliclazide Specification
Product Name: Gliclazide
CAS: 21187-98-4
Standard: BP
Natural/Synthetic: Synthetic
Level: Pharmaceutical grade
Content: 99%
Appearance: white powder
Packing: 25KG/cardboard drum
Physical and chemical properties: 170608 update 100kg 550/KG, spot
Category: Pharmaceutical Raw Materials
Field: Hypoglycemic
Deferred product: gliclazide tablets
Application: For non-insulin-dependent diabetes mellitus (type II diabetes)
Usage and dosage: 80mg orally, before breakfast or after breakfast and before lunch, 40mg, 3 times a day, three meals before serving, if necessary, the daily amount of 80mg after 7 days. The general daily dose of 80 ~ 240mg, the maximum daily dose does not exceed 320mg. Preparations and specifications: gliclazide tablets 80mg. Oral, once 80mg, started 2 times a day, and even served 2-3 weeks, then depending on the condition increase or decrease the dose, the daily dose range 80-240mg. Can cause changes in blood. Regular inspection of blood during medication. Juvenile diabetes, accompanied by diabetic ketosis, diabetic coma, etc. all need to be injected with insulin, can not use this product alone.
What is Gliclazide?
Gliclazide (Diamicron) is an anti-diabetic medication used to treat diabetes mellitus type 2. It is used when dietary changes, exercise, and weight loss are not enough.[3] It is taken by mouth.
Gliclazide Certificate of Analysis
| Product name |
Gliclazide |
| CAS No. |
21187-98-4 |
Outer Packing |
25kg/drum |
| Production date |
2018.4.25 |
Shelf life |
2020.4.24 |
| Standard adopted |
BP |
| Items of analysis |
Specification |
Results |
| Character |
White or white off powder, odorless, tasteless. Chloroform dissolved, slightly soluble in methanol, slightly soluble in ethanol, insoluble in water. |
Conforms |
| Melting point |
162~166℃ |
162.5-165.5℃ |
| UV |
Ultraviolet absorption spectra have a maximum absorption at a wavelength of 228 nm |
Conforms |
| IR |
should be consistent with the glycemic map |
Conforms |
| Loss on drying |
≤0.25% |
0.06% |
| Ignition residue |
≤0.1% |
0.02% |
| Heavy metal |
≤10ppm |
＜10ppm |
| Assay |
99.0-101.0% |
99.2% |
| Related impurities |
Neighboring gliclazide (impurity F, impurity I) ≤ 0.1% |
0.02% |
| N-nitroso (impurity B) |
≤2ppm |
0.4ppm |
| Aminoheterocyclic hydrochloride |
≤0.1% |
＜0.1% |
| Remaining solvent |
Toluene |
＜0.01% |
| Conclusion |
Qualified |
Gliclazide Side effect
Side effect may include low blood sugar, vomiting, abdominal pain, rash, and liver problems.
Gliclazide Medical uses
Gliclazide is used for control of hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, type 2 diabetes. It is used when diabetes cannot be controlled by proper dietary management and exercise or when insulin therapy is not appropriate.
